BioNews Clinical is the clinical services arm of BioNews.
We were born to facilitate the connection of our rare disease community with ongoing clinical research opportunities.
We brought together more than 2 million people living with diseases, most of which don’t yet have a cure.
The clinical trial services we offer is our own way to move research forward, faster!
WHAT MAKES US RARE
Through the stories we tell, we encourage and celebrate the joy, the hardship, and the extraordinary gift of being human. In doing so, we have built highly engaged interactive rare disease communities.
Because we rely on patients to be the experts who lead and guide our work and we listen to them, we have gained their confidence and trust.
Because we have built an inclusive culture of respect, collaboration, and empathy that brings together patients, scientists, writers, and clinical trial experts, we provide real-time, relevant, and actionable information that will help you design and conduct human-centered clinical trials.
Through our multi-channel marketing approach, we will connect you to the rare disease communities of interest to ensure meaningful engagement of patients in all phases of drug development.
Through optimized news content, our network of rare disease-specific websites and social media channels will selectively speak to people who are actively interested in learning about your clinical trial.
Our multi-channel, multi-content approach will allow you to engage with our patient communities, raise awareness, provide education and help you improve adherence, and increase participation in your ongoing trials.
THIS IS HOW IT WORKS
You provide your clinical trial IRB-approved material or the article you want to share.
Within our growing community, we specifically identify those interested in receiving your material.
Then, we disseminate and promote your campaign via a multi-channel approach for high conversion rate.
Our patients discover your landing page and click to get connected to more info.
We analyze engagement metrics that can help you measure the success of your campaign and improve your future campaigns.
COMING IN 2021
BIONEWS-LED PATIENT RECRUITMENT
Identification and referral of patients through recruitment campaigns generated by BioNews patients. BioNews will lead the IRB approval process.
What does it mean to live with one’s disease? What type of challenges do patients face? How can we design solutions to improve patients’ QoL, increase participation, and offer a dignified patient experience?
PATIENT-POWERED SOCIAL MEDIA CAMPAIGNS DEVELOPMENT
Leveraging our community’s disease specific know-how to develop effective social media campaigns that can help sponsors recruit patients more effectively and efficiently.
We can help you select endpoints that reflect outcomes meaningful to those who participate; evaluate your protocol schedule of assessments; design patient relevant QoL measurements and meaningful PROs.
Understanding of the disease process through patient insights, focus groups, advisory boards.